Digestion · 2009 · 44 citations · 0 references
MedicinePharmacologyPharmacotherapyClinical PharmacologyGastroenterologyGastrointestinal PharmacotherapyCrohn Disease PharmacotherapyGastrointestinal InflammationGastrointestinal PharmacologyInflammatory Bowel DiseaseCombination Drug TherapyInflammatory Bowel Disease PathophysiologyInflammatory Bowel Disease Therapy
A double-blind controlled clinical trial has shown no benefit from the use of sulphadoxine-pyrimethamine over a 12-month period in chronically active Crohn’s disease.